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Abstract
Background: Thymol is a phenolic compound used for its wide spectrum antimicrobial activity. There is a limited
understanding of the antimicrobial mechanisms underlying thymol activity. To investigate this, E. coli strain JM109
was exposed to thymol at sub-lethal concentrations and after 16 rounds of exposure, isolates with a 2-fold
increased minimal inhibitory concentration (MIC) were recovered (JM109-Thyr). The phenotype was stable after
multiple sub-cultures without thymol.
Results: Cell morphology studies by scanning electron microscopy (SEM) suggest that thymol renders bacterial cell
membranes permeable and disrupts cellular integrity. 1H Nuclear magnetic resonance (NMR) data showed an
increase in lactate and the lactic acid family amino acids in the wild type and JM109-Thyr in the presence of
thymol, indicating a shift from aerobic respiration to fermentation. Sequencing of JM109-Thyr defined multiple
mutations including a stop mutation in the acrR gene resulting in a truncation of the repressor of the AcrAB efflux
pump. AcrAB is a multiprotein complex traversing the cytoplasmic and outer membrane, and is involved in
antibiotic clearance.
Conclusions: Our data suggests that thymol tolerance in E. coli induces morphological, metabolic and genetic
changes to adapt to thymol antimicrobial activity.
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Background
The antimicrobial activity of many essential oils (EOs)
such as thymol and carvacrol has been widely demon-
strated [1, 2] and is assigned to a number of small ter-
penoid and phenolic compounds [3]. Thymol (C10H14O)
is a monoterpenoid phenol extracted from thyme (Thy-
mus vulgaris) as well as other plants. Thymol has been
shown to have a wide range of potential applications in
pharmaceuticals and therapeutics due to its effective
anti-inflammatory, anti-oxidant, and anti-hyperlipidemic
properties [4]. In the agriculture and food industry thy-
mol has shown potential insecticidal and antimicrobial
properties [5, 6]. Despite a large body of literature
supporting the potential antimicrobial control of EOs
and their minimal negative effects on human health,
there are still relatively few applications in real foods
due to lack of systematic studies of the single constitu-
ents of EOs and their effects either in model or real sys-
tems. However, there is some information on the
mechanisms of action of these bioactive molecules, for
example against food-borne microorganisms [7, 8]. In-
deed, a deeper understanding of the microbial targets of
EOs and their components as well as related microbial
defence systems involved may permit a greater use of
these antimicrobials in foods and food production. Re-
cent studies have reported proteomic, genomic and
metabolomic approaches to study pathogen cellular pro-
cesses and their response to antibiotic stimuli [9, 10].
These approaches could identify the mode of action of
thymol against E. coli.
Antibiotic resistance is a major cause for global burden
on health, costs, and gross domestic products [11, 12]. E.
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coli antimicrobial resistance has been shown to be most
prevalent in the agricultural industry imposing substan-
tial threats to health and production [13, 14]. Several
studies have shown EOs, especially thymol, can effi-
ciently inactivate pathogens [2, 7, 15–17] but only a few
provide insight into the EO mechanism of action. Burt
and Reinders showed morphological changes in E. coli
O157 caused by thymol [15], whereas Yuan et al. showed
that thymol tolerance induced an altered expression pro-
file supportive of resistance to thymol, heat, and oxida-
tive stress in E. coli 0157 [8]. Currently, there are many
antibiotic resistance mechanisms reported stemming
from genetic and proteomic investigations in a wide
range of pathogens [18, 19]. However, EOs effects in
susceptible pathogens relevant to the food industry has
not been equally studied [20]. More specifically, compre-
hensive analysis of changes in E. coli treated with thymol
has not been performed. Therefore, the primary purpose
of this research was to investigate the mechanism of ac-
tion of thymol in E. coli.
Results
Adaptation of E. coli to thymol
The minimal inhibitory concentration (MIC) of thymol
for E. coli JM109 was established prior to exposure to
sub-inhibitory concentrations of thymol and was
175 μg l− 1. JM109 was shown to be tolerant of up to
3.5% ethanol, and the residual concentration of ethanol
in the LB based thymol medium was 1%. The MIC of
JM109 thymol-tolerant derivative (JM109-Thyr) was de-
termined to be 400 μg l− 1 after 16 passages in gradual
increasing concentrations of thymol. Tolerance to thy-
mol was shown to be stable as demonstrated by re-
peated MIC tests in seven repeated subculture in LB
broth without thymol (the JM109-Thyr clone was
passed through every 24 h for 7 days). After testing for
stability, JM109-Thyr clone culture was plated onto an
NA plate and isolated colonies were used for subse-
quent experiments to assess JM109-Thyr mechanism of
resistance to thymol.
Growth rate for JM109-Thyr
Figure 1A shows the significant growth differences be-
tween E. coli K12 laboratory strain JM109 and its
JM109-Thyr (p = 0.001). More specifically, the JM109-
Thyr when grown in LB without thymol showed a re-
duced growth rate and yield compared to control JM109
strain (Fig. 1B). In addition, the log and exponential
phases were extended in high thymol concentrations to
more than 20 h, and in most of the thymol concentra-
tions tested it did not reach a stationary phase within
the experimental time limit (24 h).
Determination of E. coli morphology in the presence of
thymol
SEM analysis revealed JM109-Thyr (Fig. 2B) displayed
few morphological changes relative to wild-type (non-re-
sistant) cells. Figure 2A shows JM109-Thyr exhibited a
slight corrugation of the cell surface and some cell body
elongation. After exposure to sub-lethal concentrations
of thymol at 50 μg l− 1, both tolerant and wild-type cells
(Fig. 2C, D) showed morphological alterations in com-
parison to non-exposed cells (Fig. 2A, B). The wild-type
JM109 had a uniform cylindrical shape and long cells
with little evidence of septum formation. In the 23 whole
cells analysed only two (8.7%) showed indications of
septum formation. Besides these observations, the over-
all cell size of wild-type JM109 in the presence of thymol
appeared larger than wild-type cells without thymol, and
larger than JM109-Thyr whether in the presence or ab-
sence of thymol. The average length of the wild-type
strain grown in thymol was 1.57 μm whilst the average
length of JM109-Thyr strain was 1.3 μm (p = 0.01). In
addition, JM109-Thyr cells displayed more morpho-
logical changes after thymol challenge (Fig. 2D), the sur-
face appeared to be ‘rough’ and showed irregularly
shaped spots dotted along the cell body.
Metabolic profile of JM109-Thyr
Orthogonal projection to latent structure (OPLS) is a
powerful statistical modelling tool that provides insight
into separations between experimental groups based on
NMR high-dimensional spectral measurements. OPLS
explained variation (R2Y) values around 0.8 were indi-
cative of a good model, with Q2 values of ~ 0.5 indi-
cative of good predictive ability. To analyse these
complex data sets PCA analysis was performed (Fig. 3)
which in this case summarises the original 65,536 vari-
ables detected. Thus, the direction and distance covered
by the samples can be considered respective indicators
of the differences between the metabolic profiles of
each strain under the two test conditions, presence and
absence of thymol. The metabolic profile of JM109
grown in M9 medium (n = six replicates) were tightly
clustered indicating minimal sample to sample vari-
ation. However, the metabolic profile of the six repli-
cates of JM109-Thyr grown in M9 medium were more
dispersed but discrete from JM109. It is clear that the
metabolic profile of JM109-Thyr strain was different
from the wild-type, given the trajectory; suggests the
presence of fewer small metabolites than wild-type.
However, in the presence of thymol both wild-type and
JM109-Thyr were very comparable in their metabolic
profile including very similar small metabolites.
PCA score plots also indicated differences in metabolic
profiles of JM109 and JM109-Thyr. The comparison of
wild-type and JM109-Thyr grown in M9 without thymol
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(Fig. 4A) shows several peaks that correlate with energy
metabolism end products (ethanol, formate, succinate
and acetate) that were significantly higher in the wild
type JM109 than JM109-Thyr. Succinate is the inter-
mediary synthetic product of the tricarboxylic acid
(TCA) cycle, whilst formate and acetate are the end
products of the TCA cycle. These findings suggest
JM109 wild-type respired aerobically. By contrast lactate
was significantly higher in JM109-Thyr than wild-type.
Lactate is one of the main sugar fermentation products
of E. coli that is produced by hydrogenation of pyruvate.
Moreover, the aromatic amino acid phenylalanine and
other amino acids, such as leucine, valine and alanine
that belong to the pyruvate family of amino acids were
produced more by JM109-Thyr than by wild-type JM109
(Fig. 4B). Having identified metabolic differences be-
tween JM109 and JM109-Thyr grown in M9 without
thymol, we next examined the metabolic effects of thy-
mol on both strains (Fig. 4C-F). A potential confounder
of the data was the presence of 1% ethanol in both ex-
periments as thymol was dissolved in ethanol and this
molecule was therefore detected as a common feature in
both strains. Thus, the production of ethanol by either
strain would be masked by the excess already in the
medium. In E. coli wild-type (Fig. 4C-D), the end prod-
ucts of glucose metabolism featured again but fumarate
and lactate were also observed. In contrast, lactate was
observed but at reduced concentrations along with acet-
ate in JM109-Thyr (Fig. 4E-F) suggesting slower growth
in thymol possibly due to a shift from aerobic respiration
to fermentation.
JM109-Thyr genetic changes
Having established a non-reverting, genetically stable
JM109-Thyr we sequenced its genome and compared it
to the parental JM109 strain to identify mutations that
may contribute to thymol tolerance. Results show that
the parent and JM109-Thyr strains both align to JM109
reference sequences. There were some major differences
that could be ascribed to contig assembly and some re-
gional inversions between the two strains. JM109-Thyr
strain harboured a JM109 backbone and was therefore a
true derivative. Therefore, any mutations in specific
genes are likely to be those that generate the phenotype
observed. A mutation was identified in the acrR gene
that encodes a repressor of AcrAB, which is a multidrug
efflux pump. The mutation was a nonsense mutation
converting an arginine residue at position 107 to a stop
codon in the 215 amino acids long AcrR protein. The lo-
cation of the mutation in acrR was a C to T transition at
position 486,079 bases (gene size 485,761–486,408, locus
tag = “b0464”) and abolishes a conserved amino acid
residue in the C-terminal TetR domain. The other pos-
sible significant change was an Arginine to Cysteine
amino acid change (R to C) at residue 118 in the ribo-
nuclease G protein. The position of this mutation in the
rng gene is − 3,397,444: rng (gene location 3,396,326–3,
397,795 [reverse orientation], locus tag = “b3247”). Fur-
thermore, an IS5 transposase gene had multiple silent
point mutations, and the F-plasmid was missing in
JM109-Thyr.
Discussion
Widespread antibiotic resistance in bacterial species has
lead scientists to pursue alternative natural products
possessing antibacterial properties such as EOs. Thymol
has been studied for its antimicrobial potential but many
aspects of its mechanism of action have not been fully
elucidated. Here, we propose a possible mechanism of
action based on results of metabolomic and genomic in-
vestigation of an E. coli JM109-Thyr isolate. E. coli
JM109-Thyr exhibited acquired sustained a stable toler-
ance to thymol after exposure to increasing sub-
inhibitory concentrations of thymol, suggesting that in
E. coli thymol tolerance could be the result of genetic
mutation(s). It was noted that JM109-Thyr had extended
Fig. 1 The effects of increasing concentrations of thymol on the growth of the wildtype JM109 E. coli (A), and JM109-Thyr (B)
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Fig. 2 Scanning electron image of E. coli JM109 cells. (A) Thymol untreated wildtype JM109 cells; (B) JM109-Thyr thymol untreated cells; (C)
wildtype JM109 thymol treated cells; (D) JM109-Thyr thymol treated cells
Fig. 3 PCA-score plot illustrating the effect of different solvents on metabolic footprints derived from E. coli JM109 wildtype and JM109-Thyr
untreated and treated with a sub-lethal concentration of thymol (50μg l− 1). N = 6 for each sample (JM109thy: wildtype JM109 with thymol;
JM109M: JM109 thymol tolerant derivative; JM109Mthy: JM109 tolerant derivative with thymol)
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Fig. 4 (See legend on next page.)
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lag and exponential phases and a delayed stationary
phase without thymol indicating that JM109-Thyr strain
had a reduced growth rate even in the absence of thy-
mol. This finding is similar to other reports of slow bac-
terial growth in presence of terpenes to launch cellular
survival and homeostasis mechanisms to survive EO
antimicrobial action and regain replicative potential [21,
22]. Exposure to thymol conferred modest morpho-
logical changes in the cell wall and membrane of wild-
type JM109 based on SEM analysis, whereas JM109-Thyr
displayed few morphological changes relative to wild-
type cells. This suggests that thymol renders bacterial
cell membranes permeable, which is similar to other
studies that used EOs [15, 23–25]. Given these findings
it may be postulated that thymol disrupts cell membrane
structure and function including septum formation
which is essential for cellular division and population
growth. Also, since ion transport and ATP generation
are located in the cell membrane these processes may
also be disrupted. Collectively, these morphological al-
terations strongly suggest that gene regulatory processes
may be coming into play perhaps to upregulate systems
that detoxify thymol or prevent its entry, or/and increase
fatty acid synthesis to repair cell membranes and so
forth. This is an area for future research through tran-
scriptomic approaches.
NMR results gave the first clues to the perturbation
induced by thymol on E. coli metabolism. Those found
to be of particular importance in wild-type JM109 were
formate, succinate and acetate that are organic acids
present in or at the end of the TCA cycle respiratory
pathway. However, JM109-Thyr had decreased levels of
these metabolites and significantly increased lactate and
pyruvate family amino acids. This is compelling evidence
of a switch from respiration to fermentation as part of
the strategy of E. coli to survive assault with polyphenols.
The conclusion here is that increased tolerance to thy-
mol is associated with a shift away from respiration to
fermentation or the inability to enter the TCA cycle in
JM109-Thyr strain which may explain why it grew
slower than the wild-type even without thymol. Our
finding is similar to a study that used vanillin, which is a
phenylpropene phenolic aldehyde, where the mechanism
of vanillin antibacterial action was associated with inhib-
ition of respiration in E. coli whilst in some lactic acid
bacteria it disrupted K+ and pH homeostasis [26]. More-
over, a reported analysis of the metabolome of E. coli
555 by 1H NMR spectroscopy at different concentrations
of carvacrol showed that although adaptation to carva-
crol at sub-lethal doses was different from that occurring
at higher doses, towards the higher concentrations of
carvacrol there was a shift from respiration to fermenta-
tion [27]. Together these findings and those from our
study suggest that E. coli exposure to phenolic com-
pounds reduces growth which is accompanied by a shift
from respiration to fermentation. It should be noted that
lactate was already present in all samples tested suggest-
ing some fermentation, possibly through hypoxia that
occurred during growth or between harvesting and ex-
traction. Moreover, there was little evidence of small
metabolite leakage suggesting that at the concentration
of thymol used (a modest 50μg l− 1) cell membrane dam-
age was possibly minimal. Whilst this is not a direct evi-
dence for the mechanism of action, it is an interesting
possibility that phenolic compounds integrate in the cell
membrane to disrupt electron transfer that is essential
for respiration.
Genome sequencing analysis of JM109-Thyr pointed
towards two mutations leading to a potential loss of
function of genes. Firstly, a non-sense mutation in the
acrR gene encoding a repressor of the AcrAB efflux
pump, and secondly a non-synonymous missense variant
in the rng gene encoding ribonuclease G (RNase G). The
acriflavine resistance regulator (AcrR) is a local tran-
scription factor that regulates the expression of the outer
and cytoplasmic membrane bound AcrAB-TolC multi-
drug efflux pump. The AcrAB-TolC multidrug efflux
pump is involved in exporting a wide range of toxic
compounds such as antibiotics, disinfectants, organic
solvents and phytochemicals [28–31]. AcrR modulates
the expression of acrRAB genes [32] and the associated
AcrAB-TolC multidrug efflux pump [33]. The acrR gene
is divergently located 141 bp upstream of the acrAB op-
eron [32] and encodes a 215 amino acid long transcrip-
tional repressor of the TetR family. The N-terminal
domain of AcrR contains a DNA-binding motif, and the
C-terminal domain has a unique sequence that is pre-
dicted to bind ligands [34]. The binding of drugs to the
C-terminal domain of AcrR triggers a conformational
change in the N-terminal DNA-binding domain result-
ing in the release of AcrR from DNA and allowing its
transcription from its cognate promoter [35]. AcrR has
long been implicated in organic solvent and antibiotic
resistance in E. coli [36–42]. However, our reported
(See figure on previous page.)
Fig. 4 NMR spectra of JM109 wild-type and JM109-Thyr strain grown with and without thymol. (A) S-line plot of wild-type JM109 (bottom) and
JM109-Thyr (top) grown without thymol, (B) partially assigned 700 MHz 1D spectra of wild-type (black) and JM109-Thyr (red). (C) S-line plot of
wild-type JM109 grown without thymol (top) and thymol treated (bottom), (D) partially assigned 700 MHz 1D-spectra of wild-type JM109 without
thymol (black) and thymol treated (red). (E) S-line plot of JM109-Thyr grown without thymol (top) and thymol treated (bottom), (F) partially
assigned 700 MHz 1D-spectra of JM109-Thyr grown without thymol (black) and thymol treated (red). Heat map indicates product concentration
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mutation is novel and has not been reported before. In
our JM109-Thyr (ΔacrR) intracellular thymol accumula-
tion was probably lowered by enhanced action of the
AcrAB-TolC efflux pump due to loss of AcrR control.
Loss of AcrR has been shown to result in the increased
production of AcrAB-TolC efflux pumps and therefore,
persistent clearance of thymol as highlighted by sus-
tained growth of JM109-Thyr in higher concentrations
of thymol [36, 42]. In fact, Yuan et al., reported tran-
scriptomic data supporting our findings in their thymol
adapted E. coli O157:H7 bacterial model [8]. They found
that thymol adapted E. coli O157:H7 had a significantly
different transcriptomic profile under thymol stress with
113 downregulated genes limited to virulence, motility
and replication genes, and 225 upregulated genes that
included efflux pumps, stress response and iron trans-
port genes. However, the limitation of that study is the
absence of genome analysis to corroborate the altered
expression genes are not harboring any mutations in-
duced by thymol tolerance. Moreover, the limitation in
our investigation is the lack of expression data in our
evolved JM109-Thyr. In summary, inactivation of acrR is
effective in increasing the MICs of thymol in E. coli.
These results indicate that the AcrAB efflux pump plays
an important role in survival against thymol. Most prob-
ably this mechanism in the comparative ‘resistance’ to
thymol is the same mechanism created in response to
the presence of antibiotics. Therefore, AcrAB efflux
pump inactivation is a primary candidate for increasing
bacterial sensitivity to antibiotics/ phytochemicals. It
would be interesting to test this hypothesis by using spe-
cific efflux inhibitors such as phenylalanine arginyl β-
naphthylamide (PAβN).
The other interesting mutation was in RNase G which
functions in mRNA decay, tRNA and rRNA cleavage
and maturation in conjunction with other RNase E and
G family members [43]. E. coli RNase G was originally
identified as an endoribonuclease involved in the matur-
ation of 16S rRNA [44]. E. coli RNase G has been shown
to be involved in the degradation of adhE mRNA encod-
ing fermentative alcohol dehydrogenase [45, 46]. Differ-
ent mutations reported in RNase G in the S1-like RNA-
binding domain resulted in slowed growth of E. coli cul-
tures [47]. Moreover, partial deletion of rng RNA-
binding domain has been shown to enhance homoetha-
nol fermentation [48]. It is possible that our reported
missense mutation in RNase G that lies in the same
domain would similarly support the metabolic shift to
fermentation by alcohol dehydrogenase sustained ex-
pression and the noted slowed growth. Our study is lim-
ited by lack of a confirmation analysis of our reported
genetic mutations causing thymol resistance in JM109,
and the fact that our genetic findings are based on a sin-
gle thymol resistant colony isolate. It is plausible that
other colonies have adapted to thymol presence by other
genetic and metabolic alterations. In addition, it is un-
clear if our reported mutations are contributing separ-
ately or in combination to thymol tolerance. An ideal
confirmatory experiment would involve reintroduction
of found genetic mutations in JM109 wild-type genetic
background separately and in-combination to assess
their individual and combined contribution to thymol
resistance.
Conclusions
Thymol resistance in E. coli is achieved by inducing
morphological, metabolic and genetic changes. Despite
the presence of ‘protective’ mutations against thymol the
bacteria were very slow growing, were of low yield, and
their metabolic profile suggests a shift to fermentation.
It could be argued that when exposed to thymol E. coli
would be rendered uncompetitive in the environments
in which these bacteria are found which suggests that
exposure to thymol will not readily select resistant toler-
ant derivatives in the ‘real world’. However, it is worthy
to note that our observations are based on a single thy-
mol resistant isolate, other isolates may have adapted by
alternative mechanisms. If thymol and other EOs are
used in complex environments they may pose little or
even no threat of generating resistance unlike antibiotics.
Whilst tempting to speculate EOs could be the new anti-
biotics of the future, much further work is needed.
Methods
E. coli adaptation to thymol test
E. coli K12 strain JM109 (New England BioLabs, Ips-
wich, MA, USA) was used for the thymol adaptation
experiment. The test was performed after determining
the minimal inhibitory concentration (MIC) [49]. Thy-
mol was dissolved in ethanol 50% (v/v) to give a working
stock solution of 5 mgl− 1. A primary thymol concentra-
tion of 100 μg l− 1 was used for the first exposure and
thereafter increased by an additional 25 μg l− 1 increment
so that the cells would be grown in a rising series of thy-
mol concentrations (100–400 μg l− 1). For each cycle of
growth 4.5 ml of each thymol concentration was added
to Greiner CELLATAR® 96-wells plates. Five colonies of
JM109 E. coli were taken from LB plates, inoculated into
10ml of LB broth that was incubated aerobically shaking
at 200 rpm at 37 °C for overnight. When growth was
observed, 500 μl of the suspension adjusted to an
OD600 = 0.02 (about 1 × 107 CFU ml− 1) were added to
each well for the first exposure in LB broth with 100 μg
l− 1 thymol. The inoculated 96-well plate was incubated
at 37 °C with shaking for 48 h after which a sample was
streaked on to an LB agar plate and a 500 μl sample
transferred to a fresh 96-well culture plate containing a
concentration of thymol 25 μg l− 1 greater than in the
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previous well. This procedure was continued for 16 cy-
cles at which time obvious growth was observed after 48
h of incubation at 37 °C. E. coli JM109 control cells for
this experiment were grown in conditions similar to the
above mentioned conditions throughout the 16 cycles
without the addition of thymol. Both control and thymol
treated cell were were plated on LB agar and colonies
were picked and stored on cryobeads at -80 °C for subse-
quent experimentation.
Growth rate assessment
The effect of thymol on the growth of trained tolerant
and original E. coli JM109 was assessed by growing cells
in 200 μl of different thymol concentrations in 96-well
plate with 3 replicas, according to the CLSI M31-A3
guidance [50]. As a control, the last column of wells
were inoculated without thymol as a negative control.
The 96-well plate was covered with a lid and placed in
an atmospheric control unit for microplate reader the
FLUOstar Omega system (BMG LABTECH, Germany)
at 37 °C with orbital shaking (200 rpm) and run for 24 h
with spectrophotometric measurement (at 600 nm) every
hour to determine bacterial growth. Immediately after
24 h incubation, 5 μl from each well was transferred to
LB agar plates to determine the lowest concentration of
thymol at which no growth could be observed after 24 h
of incubation at 37 °C. This experiment was performed
in triplicate with three repeats on separate days.
Determination of bacterial morphology
JM109-Thyr and original JM109 strains were observed
by scanning electron microscopy (SEM). After over-
night incubation in LB broth at 37 °C, bacterial cells
were suspended to OD 600 = 0.5 in LB broth and di-
vided into two sterile Eppendorf tubes to which thymol
was added to one tube at a concentration of 100 μg l− 1,
whilst the other was left untreated as a control. Samples
were incubated in a rotary shaker set at 200 rpm and
37 °C. After 2 h, the cells were harvested by centrifuga-
tion at 14,000x g for 2 min, washed twice and
suspended in phosphate buffer saline (PBS). Each sus-
pension (200 μl) was placed on poly-L-lysine-coated
glass cover slips for 15 min on both sides. Adhered bac-
teria were fixed with a solution of 2.5% glutaraldehyde
pH 7 for 15 min. After fixation, samples were washed
with water for 15 min, dehydrated by increasing serial
dilution of ethanol (30, 50, 70, 80, 90%) immersions for
10 min each and for 1 h in 100%. Samples were dried in
a Balzers critical point dryer CPD 030 (Bal-Tec,
Germany), and metal coated in a sputter coater (Ed-
wards, UK). All samples were observed with a field
emission Quanta SEM equipped with a cold stage and a
cryo-preparation chamber (Thermo Fisher Scientific,
MA, USA). The experiment was performed in triplicate.
DNA isolation and sequencing
Trained tolerant and original E. coli strain JM109 cul-
tures grown for 18–24 h in LB were used for DNA
extraction using yeast/bact kit (Qiagen, Germany) ac-
cording to manufacturer’s protocol from fresh samples
of bacterial cultures. The DNA concentration and qual-
ity were determined with a ND-1000 Nanodrop spec-
trophotometer (NanoDrop technologies, CA, USA).
DNA stocks were adjusted to 100 ng/μl and stored at −
20 °C for sequencing. All centrifugation steps were per-
formed at 14,000x g.
JM109 and derivatives were sequenced (Illumina, CA,
USA) according to manufacturer’s protocols at 2 × 250-
bp paired–end reads platform following Illumina library
preparation. Raw sequence data were processed by an
automated analysis pipeline, and reads were trimmed
using Trimmomatic tool and the quality was assessed
using in-house scripts combined with SAM tools, Bed
Tools and BWA-mem. The genomes were assembled
with SPAdes version 3.9.0 [51], and the assembly statis-
tics were checked with Quast version 4.5 [52]. Compari-
son of the JM109 wild-type strain genome with JM109-
Thyr genomes was performed using Mauve multiple
alignment program [53] and annotation with Prokka
[54]. Results refer to positions on a reference E. coli gen-
ome as “universal” coordinates using the first published
K-12 genome the E. coli MG1655 strain. MG1655 se-
quences were retrieved from GenBank (www.ncbi.nlm.
nih.gov/nuccore/NC_000913.3) with accession number
NC_000913. The E. coli MG1655 genome has been com-
pletely sequenced and the annotated sequence, biochem-
ical information, and other available information were
used to reconstruct the E. coli metabolic map [55].
1H nuclear magnetic resonance (NMR) spectroscopy
Prior to analysis, frozen stock suspensions of wild-type
E. coli JM109 and JM109-Thyr were cultured overnight
in 5 mL of LB medium at 37 °C with shaking at 200 rpm.
For the NMR metabolomics analysis, 200 μl of the over-
night culture was re-inoculated in 10mL of M9 defined
minimal medium with glucose (0.2% w/v) as carbon
source and thiamine supplement [56]. On the day of ex-
periment, filtered M9 solution was supplemented with
FeSO4 (2 μM/mL) and 1X trace metal mix solution
(Sigma Aldrich, UK) and pre-warmed to 37 °C prior to
inoculation as described. Subsequently the culture was
incubated at 37 °C with shaking to an OD600 of 0.6 and
was used for thymol treatment. Cultures were exposed
to a sub-lethal concentration of thymol (50 μg l− 1), con-
trols were cultured without thymol, and un-inoculated
M9 media with or without thymol. There were 6 repli-
cates for each of the treatments and incubation was for
24 h at 37 °C. Each 10 ml culture or control was centri-
fuged at 1000x g for 20 min at room temperature and 1
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ml of supernatant samples were collected immediately
afterwards and stored at − 80 °C until 1H NMR measure-
ment. Supernatants were defrosted from − 80 °C and
vortexed. A volume of 400 μl was transferred to a clean
microfuge tube. Each sample was buffered with 200 μl
phosphate buffer, vortexed and centrifuged at 14,000x g
for 10 min, after which 550 μl of supernatant was trans-
ferred into 5 mm internal diameter NMR tube on the
day of analysis.
1H NMR spectra were acquired on a Bruker (Bruker
Avance III HD, UK) 700MHz, using an automatic tuning-
matching unit at 298 K, and an automatic sample changer.
To facilitate compound identification, 1D spectra were
acquired using standard Bruker 1D nuclear over Hauser
enhancement spectroscopy (NOESY) pre-saturation pulse
sequence on selected samples [57, 58]. After acquisition,
spectra were manually phased, processed in order to re-
align spectrum phasing calibration on TSP at δ 0.00 ppm
and baseline correction using MestReNova® software.
Stacked spectra were imported into MATLAB (R2015b)
MathWork® software where spectra were digitised be-
tween δ 0.5–10 ppm in order to delete useless information
and avoid data bias; the region containing the water peak
was deleted between δ 4.8 and 5.1. Peak assignment was
done using online open access databases (chenomx® and
HMDB) and 1D Spectra (for spectroscopy correlation) for
molecule identification.
Statistical analysis
For 1H NMR metabolic analysis, 6 samples were prepared
respectively using 6 biological replicates. Multivariate stat-
istical analysis was done using principal component ana-
lysis (PCA) plots to evaluate the metabolic variations
existing between groups. Orthogonal projection to latent
structure (OPLS) regression was performed on a mini-
mum of 6 replicates per group, and between each group.
PCA and OPLS correlation plots were produced to visual-
ise differences in the metabolome between treatment
groups. Loading and contribution plots were extracted to
reveal the variables that bear class discriminating power.
Moreover, to improve model visualization and interpret-
ation, S-line plots were extracted to detect metabolites
that influence variable selection as they display the overall
importance of each variable (X) on all responses (Y) cu-
mulatively over all components.
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